When will Anduril officially announce an IPO?

Early Anduril investors utilized funds now approaching maturity. Founders Fund, which led Anduril's Seed round in 2017 ^{[^]}, likely invested from Founders Fund VII, a fund established in 2017 ^{[^]}. Similarly, Andreessen Horowitz led Anduril's Series B in 2019 ^{[^]}, primarily deploying capital from its Late Stage Venture Fund V, which has a 2016 vintage ^{[^]}. At the time of the 2019 investment, Fund V was explicitly referred to as their "current late stage fund," indicating its active use despite a new late-stage fund announcement that same year ^{[^]}.

Maturing funds create significant pressure for near-term liquidity events. Given the standard 10-12 year lifecycle for venture capital funds, these investments are nearing critical milestones. Andreessen Horowitz's Fund V, with its 2016 vintage, will reach its 10-year anniversary in 2026 and its 12-year mark in 2028 ^{[^]}. This places general partners under considerable pressure to achieve a liquidity event, such as an IPO or acquisition, for their limited partners by the end of 2026. Founders Fund VII, a 2017 vintage fund, will also approach its 10-year mark in 2027 ^{[^]}, further contributing to the urgency for an exit. The timing suggests a strong incentive for these key early investors to realize returns on their Anduril investment within the next few years.

Anduril's major defense contracts offer varying immediate revenue recognition timelines. Anduril Industries has secured significant defense contracts, including the US Air Force's Collaborative Combat Aircraft (CCA) program and Australia's A$1.7 billion Ghost Shark XL-AUV contract ^{[^]}. Understanding the revenue recognition schedules for these key programs is crucial for assessing potential bookable revenue in specific fiscal years, particularly for strategic financial disclosures like an S-1 filing. These contracts present differing timelines for significant revenue milestones, which would influence the optimal timing for such a filing.

The CCA program's substantial revenue is weighted towards later fiscal years. While Anduril is progressing with the development phase of the US Air Force's CCA program ^{[^]}, the most significant revenue milestones tied to large-scale procurement are anticipated in subsequent years. The Air Force intends to begin procuring the first CCA drones in 2027, with a request for nearly $1 billion allocated for this initial acquisition phase ^{[^]}. Consequently, though development work may contribute some revenue in FY2025 and FY2026, the primary booking events from full-scale acquisition are largely expected from FY2027 onward, diminishing their role as immediate growth drivers for FY2025.

Ghost Shark program promises significant, earlier revenue milestones for Anduril. In contrast, Australia's A$1.7 billion Ghost Shark XL-AUV program presents a more immediate opportunity for substantial revenue recognition. This contract, awarded to Anduril Australia, was formally designated a Program of Record around September 2025 ^{[^]}. This designation signifies a transition to a more established procurement phase. Given the considerable contract value and its Program of Record confirmation in 2025, it is highly probable that significant revenue milestones from the Ghost Shark program will be realized and bookable in FY2025, with contributions continuing into FY2026 and beyond. This earlier timeline for the Ghost Shark program could provide a more favorable immediate revenue narrative for a potential S-1 filing compared to the later procurement schedule of the CCA program.

Anduril Industries recently posted an investor relations role, indicating potential IPO steps. Approximately three weeks ago, Anduril posted a job opening for a 'Manager, Investor Relations' ^{[^]}. This role, while not explicitly titled 'Head of Investor Relations,' involves managing investor relationships, a key function typically established or expanded when preparing for an initial public offering (IPO). The timing of this job posting falls within the specified six-month timeframe, suggesting a potential move towards future public market engagement.

Recent leadership appointments for other specific IPO roles were not identified. Brian Bell holds the position of VP Controller at Anduril ^{[^]}, and Babak Siavoshy is the current Chief Financial Officer ^{[^]}. However, available sources do not indicate that either individual was a new hire within the last six months, nor are their titles explicitly 'VP of SEC Reporting.' While market discussions about a potential Anduril IPO in 2026 exist ^{[^]}, the presence of existing leadership in these key finance roles, without clear indication of recent appointments for specific IPO-precursor titles, suggests ongoing operations rather than a newly formed IPO team for these particular positions within the last six months.

Anduril's private valuation implies a 14.17x forward revenue multiple. The company's December 2022 valuation of $8.5 billion, utilizing an estimated $600 million in 2023 revenue, yielded an approximate forward revenue multiple of 14.17x ^{[^]}. This figure reflects Anduril's valuation at that time relative to its projected revenue for the subsequent year.

Palantir's public multiple slightly exceeds Anduril's private multiple. Palantir Technologies (PLTR), a public defense-tech company, currently trades at a forward price-to-sales multiple of 15.68x for 2024 ^{[^]}. This demonstrates that Palantir's present public market forward revenue multiple is slightly higher than the implied forward revenue multiple calculated from Anduril's December 2022 private valuation.

Major venture-backed IPOs from late 2023 saw lock-up expirations in March 2024. ARM Holdings plc's ordinary shares became available for potential trading by company insiders on March 12, 2024, following the conclusion of its lock-up agreement ^{[^]}. Instacart (Maplebear Inc.) experienced a lock-up termination for certain Restricted Stock Units (RSUs) on March 17, 2024 ^{[^]}, although an earlier termination event occurred around January 23, 2024 ^{[^]}. Klaviyo also saw its lock-up expire for certain Series B Common Stock on March 18, 2024 ^{[^]}.

Lock-up expirations release shares, potentially impacting stock performance and investor sentiment. When these periods conclude, a substantial volume of shares enters the public market, which can generate selling pressure and adversely affect stock prices. The capacity of the market to absorb these newly available shares, along with the subsequent investor response, are crucial considerations for financial advisors. These advisors leverage such factors to guide companies like Anduril on the optimal timing for launching new technology IPO roadshows.

Catalyst analysis unavailable.